While many proteins were extensively phosphorylated and minimally OGlcNAcylated, proteins found to be extensively O-GlcNAcylated were almost always phosphorylated to a similar or greater extent, indicating the O-GlcNAcylation system is specifically targeting a subset of the proteome that is also phosphorylated. Both PTMs usually occur on disordered regions of protein structure, within which, the location of OGlcNAcylation and phosphorylation is virtually random with respect to each other, suggesting that negative crosstalk at the structural level is not a common phenomenon.
Introduction
O-GlcNAcylation, the addition of a single sugar (β-N-acetylglucosamine) to serine and threonine residues on intracellular domains of proteins, is a regulated, reversible post-translational modification. The O-GlcNAcylation state of proteins is responsive to numerous cellular stimuli, including nutrient levels and stress. The addition of this posttranslational modification is catalyzed by a single enzyme known as uridine diphosphate-N-acetylglucosamine:peptide -N-acetylglucosaminyltransferase, referred to as O-GlcNAc-transferase (OGT), and it is removed by a single enzyme known as Oglycoprotein 2-acetamido-2-deoxy-β-D-glucopyranosidase, referred to as O-GlcNAcase (OGA) (1) . Both of these enzymes are highly expressed in the brain. The physiological roles of protein O-GlcNAcylation may be particularly important in the central nervous system (2) (3) . OGT is present in dendrites and axon terminals; it is also associated with microtubules (4). Neuron-specific deletion of OGT results in neonatal lethality due in part to abnormal neuronal development and motor deficits (5) .
Because O-GlcNAcylation modifies serine and threonine side chains, there is the potential for interplay between the function(s) of this moiety and those of phosphorylation. Over 1000 proteins have been identified as O-GlcNAc modified. While the majority of these are also phosphorylated (6) , the implications of this are unclear given that the majority of all cellular proteins are probably phosphorylated. In most cases, the exact site of O-GlcNAc modification within a protein is still unknown.
Traditional biochemical analysis has revealed numerous proteins that have been shown to be both phosphorylated and O-GlcNAcylated, including c-Myc, nitric oxide synthase, RNA polymerase II, synapsin I, tau, and amyloid precursor protein (reviewed in (6) . In cell culture, modulation of the global levels of phosphorylation is accompanied by changes in O-GlcNAcylation levels of many proteins, and vice versa (7) (8) . However, the specific sites involved have not been reported (6) . Furthermore, pharmacological inhibition of a kinase causes a complex response, with an increase in O-GlcNAcylation of some proteins and a decrease in others (9) . A mechanistic explanation of results from these experiments is lacking.
Cross talk has been proposed at the cellular level based on experiments inhibiting or promoting either O-GlcNAc or phosphorylation levels directly and examining what effect these treatments have on levels of the other PTM. For example, cells have been treated with lithium to inhibit GSK-3 (9) , resulting in identification of 10 and 19 proteins with increased and decreased levels of O-GlcNAcylation, respectively.
Inhibition of the O-GlcNAcase in NIH-3T3 cells resulted in elevated O-GlcNAcylation levels, which in turn was correlated with increases or decreases in over 50% of the measured phosphorylation sites (7) . Over-expression of the O-GlcNAc transferase resulted in decreased phosphorylation in 17% of phosphorylation sites and increased phosphorylation at 7% of sites (10) . Interpretation of these studies is complicated by the fact that the stimulation approaches were non-physiological and resulted in widespread changes in cellular physiology. For example, if over-expression of OGT altered activity of a kinase, all phosphorylation changes, however far downstream, might be interpreted as evidence for crosstalk between the PTM systems. In general, these studies have not established unambiguously that individual protein molecules showing an increase in OGlcNAcylation also had a change in phosphorylation (or vice versa).
Driven by advances in affinity chromatography and the development of several generations of even more powerful tandem mass spectrometers (11) (12) , our knowledge of the complexity and extent of cellular phosphorylation is still growing dramatically. In contrast, our knowledge of O-GlcNAcylation is progressing slowly, due to less robust enrichment methodologies and lack of suitable, broadly applicable and sensitive mass spectrometric methodologies.
Early tandem mass spectrometric studies required relatively large amounts of individual proteins and were successful in the assignment of sites of O-GlcNAc modifications in -crystallin (13) as well as of both O-GlcNAc and phosphorylation sites in isolated serum response factor (14) . These studies on O-GlcNAcylation employed traditional collision-induced dissociation (CID); however, this common internal energy deposition technique suffered from the instability of the sugar group upon vibronic energy deposition in the gas phase (15) . Therefore, while O-GlcNAcylated peptides could be identified readily by the shift in their molecular weights by 203 Da, the assignment of the exact site of modification within a peptide required care in adjustment of minimal collision energy. Later, using the widely available CID MS technique, derivatization strategies such as beta-elimination/Michael addition were pursued to alleviate the site assignment problem (16) (17) . Recent work has addressed the need for O-GlcNAc-specific peptide enrichment based on both lectin chromatography a (18) (15) (19) and derivatization of O-GlcNAcylated peptides with biotinylated reagents (20) (10). The recent electron capture and electron transfer dissociation (ECD and ETD, respectively) techniques allow dissociation of peptide backbone linkages without causing elimination of O-GlcNAc-moieties from O-GlcNAcylated peptides. Thus, the formation of O-GlcNAc-containing sequence ion series permits unambiguous site localization without the need for derivatization (15) .
In the present work, we established a workflow that permits the combined 
Experimental Procedures

Preparation of mouse synaptic membranes
Synaptic membrane samples were purified at 4ºC, as described previously (21) in Preparation of the lectin weak affinity chromatography column 300 µg of POROS Al resin (Applied Biosystems) was reacted with 25 mg of WGA per the manufacturer's instructions. Briefly, 10 mM bicine, pH 7.5 was used as the reaction buffer and 5 mg/ml sodium cyanoborohydride was added along with 200 µl 2M sodium sulfate. The mixture was rotated at 21°C for 24 hours. The resin was spun down and washed with 10 ml bicine, then quenched with 10 ml 200 mM Tris/acetate buffer, pH 7.5 and 200 µl sodium cyanoborohydride (100 mg/ml). The resin was then packed into a 2 x 250 mm stainless steel column.
Enrichment of GlcNAcylated peptides using a WGA column
Peptides were resuspended in 50 µl buffer A (100 mM Tris pH 7.5, 150 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2 , 5% acetonitrile). Peptides were run over the column at 125 µl/min.
GlcNAcylated peptides eluted as an unresolved smear on the right side of the flow through tail peak. After 1.3 ml, an additional 100 µl of 20 mM GlcNAc in buffer A was injected to elute any remaining peptides. A GlcNAc-enriched fraction was collected between approximately 1.3 and 3.7 ml. To decrease the chance of overloading the column each 10 mg portion was split into two 5 mg samples and run separately and the GlcNAc enriched fractions were combined subsequently. For subsequent rounds of enrichment, the pooled fractions were run together in a similar fashion as before. In subsequent rounds, the GlcNAc-enriched fraction was also collected from 1.3 ml to 3.7 ml.
Enrichment of phosphorylated peptides using titanium dioxide
Peptides were resuspended in 250 µl buffer B1 (1% TFA, 20% acetonitrile). The samples were run at 80 µl/min in buffer B1 over an analytical guard column with a 62 μl packing volume (Upchurch Scientific, Oak Harbor, WA USA) packed with 5 μm titanium dioxide beads (GL Sciences, Tokyo Japan) (22) . The column was rinsed with H 2 O, then eluted with 3 x 250 μl saturated KH 2 PO 4 followed by 3 x 250 μl 5% phosphoric acid. A switching valve was used to direct these elutions onto a C 18 macrotrap peptide column (Michrom Bioresources, Auburn, CA, USA). The peptides were washed with H 2 O then eluted with 50% acetonitrile, and this solution was lyophilized to dryness using a SpeedVac concentrator.
High pH Reverse Phase Chromatography
High pH RP chromatography was performed using an ÄKTA Purifier (GE Healthcare, Piscataway, NJ, USA) equipped with a 1 x 100 mm Gemini 3µ C18 column (Phenomenex, Torrance, CA). Individual GlcNAc-enriched or phospho-enriched fractions loaded onto the column in 1% buffer A (20 mM NH 4 FA, pH 10). Buffer B consisted of buffer A with 50% acetonitrile. The gradient went from 1% B to 21% B over 1.1 ml, to 62% B over 5.4 ml, and then directly to 100% B. The flow rate was 80 µl/min. 20 fractions were collected and dried down using a SpeedVac concentrator. 1 mg of the GlcNAc-and phospho-depleted flow through material was separated by high pH reverse phase to collect 60 fractions.
Mass Spectrometry Analysis
All peptides were analyzed on an LTQ Orbitrap Velos equipped with a nanoAcquity UPLC. GlcNAc-enriched fractions were analyzed using electron transfer dissociation (ETD). Phospho-enriched fractions were analyzed using collision activated dissociation (CID). Non-modified peptides were analyzed using HCD. Peptides were eluted using a 90 minutes gradient. MSMS peaklists were extracted using the PAVA program (23) . Data was searched against the UniProt Mus Musculus database (downloaded January 11, 2011; 72932 entries) using Protein Prospector (version 5.10.0). To this database, a randomized version was concatenated to allow determination of false discovery rates. The cleavage specificity was set to "trypsin", allowing for one missed cleavage. Carbamidomethylation of cysteine residues was set as a fixed modification. Acetylation of protein amino termini, oxidation of methionine residues, pyrolization of amino terminal glutamine residues, and loss of protein terminal methionine residues were set as variable modifications. For the main GlcNAc search, 
Calculations of expected versus observed frequencies.
The expected versus observed crosstalk between the two types of PTMs was determined in three different contexts. In all cases, the analysis was restricted to peptides where the site of modification was assigned with a false localization probability of less than five percent (25) . (1): For crosstalk at a single residue, we restricted the entire analysis to the portion of each protein predicted to be in disordered regions in order to maximize the probability that all the serine and threonine residues we were considering were accessible for modification. Of the 135 observed alternatively modified residues, 96 were on disordered regions. For each protein, we then counted the number of times a residue was observed to be both O-GlcNAcylated and phosphorylated in different experiments. For that protein, we then calculated the number of residues expected to be alternatively modified by chance as n * r g * r p , where n represented the number of serine and threonine residues on that protein and r g and r p
were the rates of O-GlcNAcylation and phosphorylation, respectively for the same protein (calculated as the number of each modification over the total number of serine and threonine residues). The total expected number of alternatively modified residues was determined by summing across all proteins and this was compared to the observed value using  2 evaluation. (2) For crosstalk within sequence proximity level, we compared the observed versus expected values for the number of times an OGlcNAcylation event was observed at a distance of n residues from a phosphorylation,
for different values of n along the protein sequence. Thus, for each O-GlcNAcylation, we counted the number of phosphorylations at distance n to create a distribution of observed distances. Expected distances were calculated as n * r p limiting the serine and threonine residues to those also at distance n. Values of n were binned in intervals of five to create a larger sample size. Expected values were compared to observed values at each bin interval using  
Structural Analysis of PTMs
For proteins with an experimentally determined atomic structure or a 'good quality' (defined as a model being evaluated with a GA341 score of > 0.8 (28) comparative model in ModBase (29)), secondary structure assignments for each residue were computed by DSSP (30) . For proteins without structural information, secondary structure was predicted from sequence using PSIPRED (31) . For all proteins, disorder was predicted from sequence using the DISOPRED algorithm with the default five percent false positive threshold parameter. The median length of disordered regions was 28 residues, in line with expected values (32) . To assess the distribution of PTMs with respect to protein kinase domains, ATP binding sites, and proton acceptor sites, the corresponding amino acid ranges and positions were obtained from Uniprot (uniprot.org). If this information was not annotated for a given entry (as was the case for some TrEMBL entries), the homologous Swiss-Prot entry was used.
Protein-Protein Docking
Known OGT substrate proteins with an experimentally determined atomic structure or comparative models in ModBase (29) with greater than 85% sequence identity (to limit to models likely to be of near-native quality) were docked to Chain A of the open OGT structure (PDB ID 3PE4) using PatchDock (http://bioinfo3d.cs.tau.ac.il/PatchDock/) (33).
26 O-GlcNAcylation sites from 20 substrate proteins (B1ATI9-T34, O88935-T262, P01942-S53, P05064-S354, P12787-S100, P14094-S160, P18760-S8, P60710-S199;-S365, P62874-S136, P68134-S241, P70365-T642, P97315-S192, Q3UHK5-S45;-S559;-S650, Q80X68-T454, Q8K4S1-S2139, Q8VC88-S159, Q9CWF2-T285, Q9CZ13-T217, Q9D1Q6-T367;-S380;-S381, Q9JKV1-S211;-S213) were docked to a truncated version, residues 467-1031, of Chain A of the open OGT structure, which excludes the TPR domain. Two distance constraints were applied to each of the substrate proteins.
Atom 1462 in the 3PE4 structure, the nitrogen atom on the catalytic H498 of OGT, was required to be within 13.5 Å of the oxygen atom on the serine or threonine to be OGlcNAcylated. Atom 11140 in the 3PE4 structure, an oxygen atom on the α-phosphate of UDP, was required to be within 13.0 Å of the nitrogen atom on the serine or threonine residue to be O-GlcNAcylated. A clustering RMSD of 4.0 Å and the default complex type were used. Using the link provided on the PatchDock results page, the best 100 solutions were further automatically refined using FireDock (34). The following substrates had O-GlcNAcylation sites that were not successfully docked: A2AA49;
O08599; P08249; P14094; P48962; P56480; P60710; P62874; P68134; P68369;
Q03265; Q80X68; Q91VR2; Q9CWF2; Q9CWS0; Q9JKV1)
Results
Abundance of O-GlcNAcylation and phosphorylation
We developed a workflow to sequentially enrich O-GlcNAcylated and phosphorylated peptides from tryptic digests of mouse synaptosomes, which also allowed for analysis of the protein content from the PTM-depleted sample ( Figure 1A ).
O-GlcNAcylated peptides were isolated using three rounds of lectin weak affinity (Tables S1-3 ). As we have previously reported, our enrichment technique using the lectin wheat germ agglutinin (WGA) also enriches for N-GlcNAcylated peptides (15) . In our current analysis, we found 546 N-HexNAcylated peptides (Table S4) . While WGA has been reported to be selective for GlcNAcylated peptides and proteins (35), we have identified 181 peptides in the WGA-enriched fractions that are potentially O-GalNAcylated based upon subcellular localization of the modification (Table S5) .
Efficiencies of PTM-detection
A major factor affecting whether or not a given peptide is detected in a proteomic study is its relative abundance (36) . To estimate how efficiently we identified sites of O- Overall, this finding suggests that while we were able to identify large numbers of both PTMs, we are not identifying all PTM-modified peptides present in the sample, particularly not those originating from lower abundance proteins. This is most likely due to the fact that when a given analysis does not identify all the components in a mixture, there is a strong bias towards acquiring MS/MS on higher abundance components.
Based upon the average modifications per protein for the most abundant/thoroughly characterized proteins, we now can postulate the existence of at least 3,400 O-GlcNAcylation sites and 39,000 phosphorylation sites for the 6,621 proteins identified in our synaptosome preparation. Using the same rationale, we estimated that we identified approximately 51% and 42% of the O-GlcNAcylation and phosphorylation sites in our sample, respectively.
Mass spectrometric characterization of PTM-modified peptides
Multiple sites of O-GlcNAcylation were found close in protein primary sequence.
We observed 130 instances where the same peptide sequence was found singly O- we found 66 peptide sequences that were simultaneously modified by both phosphorylation and O-GlcNAcylation (Table S6 ). One such example is the peptide RASQp(SS)LESSTGPSYgSR, shown in Figure S2C . Figure S2B shows an example of an N-GlcNAcylated peptide with the sequence LNGTDPIVAADSKR from the Prolowdensity lipoprotein receptor-related protein 1, modified at aspargine 2.
PTM sequence motifs
Previous analyses, based on a significantly smaller scale O-GlcNAcylated peptide dataset, suggested a PVXS/T motif for substrates of OGT (18) . While this motif is found in a subset of modified peptides in this study, the majority of our OGlcNAcylation sites fit this motif poorly. In fact, less than 20% of our modified peptides display this motif. Figure 3E shows a weblogo representation of the amino acid residues surrounding the modified serine/threonine residue. There is a moderate preference for a proline residue either two or three residue positions amino-terminal to the site of modification (the -2 and -3 positions). There is also a slight preference for valine residues at either -1 or -3 positions. Overall, O-GlcNAc appears to be targeted towards regions on substrates rich in serine/threonine residues, as evidenced by an increased frequency our detection of these residues within the five residue region around the modification site that we examined. Such a preference for serine/threonine rich stretches may help explain our finding 439 multiply O-GlcNAc-modified peptides. In summary, these observations suggest that OGT does not recognize the exact primary sequence on substrates.
To investigate motifs within our phosphorylation dataset, we used Motif-X to search for over-represented patterns (38) . We find that a total of 56 distinct sub-motifs show statistically significant overrepresentation (Table S7) preference for small/non-polar residues. In addition, due to the prevalence of prolinedirected kinases in the mammalian kinome, there was an increased probability of having a hydrophobic residue at the +1 position. Finally, we examined those serine/threonine residues showing co-modification by both PTMs. This subset had a motif most similar to that of the overall O-GlcNAcylation motif. We compared these motifs to the population of serine/threonine residues not found to be PTM-modified. Hydrophobic residues are most prevalent at all positions immediately surrounding these serine/threonine residues ( Figure 3I ).
O-GlcNAcylation and phosphorylation on PTM-modifying enzymes
We identified one site of O-GlcNAcylation on OGT, on the carboxy-terminal tail.
However we did not identify any phosphorylation on OGT despite the protein being present at relatively abundant levels (28 unique peptides identified) in our synaptosome preparation. Six unique phosphorylation sites on OGT from mitotically active cells have been previously identified (39) . On the O-GlcNAcase, we identified two sites of phosphorylation and no sites of O-GlcNAcylation. We identified 280 and 87 proteins in Gene Ontology annotated with the protein kinase (GO:0004672) and phosphatase activities (GO:0004721), respectively. Kinases were more frequently phosphorylated than proteins in the full dataset (66% versus 48%, p < 3. With respect to the two kinase domains that were modified, in the first instance (CaMKII α) the O-GlcNAcylation site was more than 100 residues from either the proton or ATP acceptor site. In the second instance (CaMKII β), the O-GlcNAcylation site was 41 residues from the proton acceptor site. While it is possible that O-GlcNAc may be modifying kinase regulatory domains, it does not appear to be directly affecting kinase catalytic ability or the ability of the catalytic domain to interact with substrate proteins.
For several CaMKII isoforms, we observed O-GlcNAcylation of threonine 306/307 (in α and δ, respectively). Upon auto-phosphorylation, this residue inhibits calmodulin binding to CaMKII (40) . The phosphorylation state of the adjacent threonine 305 and threonine 306 residues in CaMKII α modulates LTP (41). We detected 11 sites of phosphorylation on CaMKII α, but did not identify phosphopeptides corresponding to threonine 306 or 307. The PTM's of CaMKII α are mapped on its homology-based structural model in Figure S3 .
Modeling OGT interactions with its substrates
A recent solved crystallographic structure of human OGT in complex with an OGlcNAcylated peptide and a tetratricopeptide repeat (TPR) domain gave insight into possible factors mediating interaction specificity with the enzyme and its substrates (42) . First, the contacts between the enzyme and peptide were made primarily through the peptide main-chain atoms, indicating that peptide side-chain identity does not play a strong role in substrate recognition ( Figure 3E ). The possibility exists that this specificity is determined through enzyme-substrate interactions distal to the active site. Second,
the TPR domain appears to restrict substrate access to the active site, leading to speculation that the TPR domain swings out in a hinge motion prior to OGT-substrate complex formation. We examined the catalytic face of OGT with the TPR domain Using the docked conformations of these 26 substrates, we searched for interactions between OGT side-chains and residues structurally conserved across multiple substrates. While we observed no fully conserved interactions, we identified four charged patches conserved across subsets of substrates that interact with oppositely charged residues on the enzyme ( Figure 4C -G).
Secondary structural elements involved in modification of substrate proteins
To gain insight into what secondary structure context may be needed for OGlcNAcylation and phosphorylation, we determined the frequency with which they appeared on loops, -helices, and -sheets. The secondary structure states of all residues in a solved structure or a good quality comparative model were assigned by the Define Secondary Structure of Proteins (DSSP) program (30) . For substrate proteins without known or modeled structures, the secondary structure states were predicted by the PSIPRED program (31) . Relative to the distribution of these structural elements in general, both O-GlcNAcylation and phosphorylation moieties were enriched within loops and relatively less prevalent within sheets and helices ( Figure 5A ). For both PTMs, the site of modification occurred on loops for approximately 90% of the sample.
We then calculated to what extent the two PTMs were found in ordered versus disordered regions of protein structure. Both phosphorylation and O-GlcNAcylation were approximately six-fold more likely to occur on disordered rather than ordered regions of protein structure ( Figure 5A ), in agreement with a previous observation for phosphorylation (43) .
O-GlcNAcylation and phosphorylation on individual proteins
To investigate how these two PTMs might be coupled at the level of individual The only protein that appeared heavily O-GlcNAcylated (13 sites) with no observed phosphorylation was CCR4-NOT transcription complex subunit 1. CCR4-NOT was amongst the 20% most abundant proteins in our preparation as estimated by the emPAI value. As a transcription factor, this protein is likely to partition between the nucleus and cytoplasm (for a review see (44) ). Regulation of gene transcription is a protein functional class known to be preferentially O-GlcNAcylated (45) . Only one site of phosphorylation on CCR4-NOT has been reported (46) . Since only a minor fraction of this protein was likely present in our synaptosome preparation, it is possible that analysis of a total cell lysate (rather than of a specific compartment) would reveal additional sites of CCR4-NOT phosphorylation.
Substrates of OGT in general appear to consist of a subset of kinase targets. The fact that the extent of potential protein O-GlcNAcylation tracks with the extent of potential protein phosphorylation is consistent with OGT and serine/threonine kinases using similar mechanisms to target substrates. For example, a portion of OGT has been reported to occur in complex with catalytic subunits of protein phosphatase 1 (47) .
Sites that are modified by either PTM
As noted above, in 135 instances, we observed phosphorylation and OGlcNAcylation of the same residue, representing 8% of the identified O-GlcNAcylation sites found in this study. This number of alternatively modified sites suggests coupling between these two PTM systems; however, given the extensive number of phosphorylation and O-GlcNAcylation sites we identified in this study, it is expected that both PTMs would map to the same amino acid residue at some frequency by chance alone. If these two PTM systems have evolved to crosstalk functionally, the observed frequency with which the same residue was found modified by both PTMs should substantially exceed the frequency predicted by chance alone. We assumed that all serine and threonine residues on disordered regions were accessible to enzymatic modification (which was not necessarily the case for serine and threonine residues in ordered protein regions). We therefore limited our analysis to disordered regions.
Approximately 50% of all serine and threonine residues are in disordered regions, and 96 of our 135 observed alternatively modified sites mapped on disordered regions ( Figure 5A ). For a given protein, the number of alternatively modified sites expected by chance alone is modeled as the rates of phosphorylation and O-GlcNAcylation on disordered regions for that protein multiplied by the total number of disordered serine and threonine residues. Summing the expected alternatively modified residues across all proteins in our dataset resulted in 96.4 sites of alternative modification expected by chance alone. Therefore, while both PTMs are preferentially targeted to disordered regions of protein structure, within these disordered regions, we find no increased propensity for alternative modification.
Relationship between the two PTMs with respect to primary structure
Spatial proximity between sites of O-GlcNAcylation and phosphorylation has been posited as a mechanism for crosstalk (6), whereby addition of one PTM will impact on the odds of the other via electrostatic or steric factors. If an organism has evolved to utilize such a mechanism, sites of O-GlcNAcylation should display an increased propensity to be localized in spatial proximity to sites of phosphorylation. We tested this hypothesis using two different representations of spatial proximity. The first computes proximity as the number of co-occurrences within a given number of residues along the protein sequence ("sequence proximity") and the second computes it as the number of co-occurrences within a given three-dimensional distance in solved substrate structures ("3D proximity"; next section). For each, we compared the number of observed cooccurrences within different distances to the number expected by chance alone.
To calculate the expected number of co-occurrences in sequence proximity for a given protein and residue distance cutoff, we multiplied the phosphorylation rate for that protein by the number of serine and threonine residues within the distance cutoff of each observed O-GlcNAcylation, and summed the results for all observed OGlcNAcylations in that protein. We found that there was essentially no increase in the number of observed alternative modifications at close distances (i.e., fewer than ten residues) in sequence proximity relative to that expected by chance alone ( Figure 5E ).
We compared this distribution to the propensity of phosphorylation sites to cluster within a protein. We calculated the expected versus observed number of phosphatephosphate co-occurrences at different distances in sequence proximity using the same approach as for phosphorylation -O-GlcNAcylation and detected a significant enrichment ( Figure 5C ) similar to that reported previously (48) (49) (50). We then examined the same enrichment of observed versus expected co-occurrences of pairs of O-GlcNAcylation modifications ( Figure 5D ) and detected a similar propensity to cluster.
While there is a slight increase in the number of observed phosphorylation -OGlcNAcylation co-occurrences relative to that expected by chance, it is significantly less than the robust increase in co-occurrences found within each type, indicating there is not strong evolutionary pressure for crosstalk through sequence proximity between OGlcNAcylation and phosphorylation. In addition, our observation of 66 peptide sequences simultaneously bearing both PTMs (Table S6) demonstrates that electrostatic/steric factors do not strictly prohibit simultaneous alternative modification by both PTMs nearby in primary sequence distance.
Relationship between the two PTMs with respect to tertiary structure
While sequence proximity between PTM pairs is a proxy for the underlying 3D distance, we could not calculate this value for all pairs since most of our OGT substrates lack solved angstrom level structures. Nevertheless, of the 285 proteins with both types of PTMs, 52 had such a structure or comparative model available covering both sites of modification. For these, we counted the number of observed phosphorylated residues within a given 3D distance of each O-GlcNAcylated residue, using shells of increasing radii. We compared this observed value to that expected by chance, using the phosphorylation rates and total number of serine and threonine residues at the same distance, as was done in the sequence proximity analysis. We found that there was no enrichment for co-occurrences relative to that expected by chance ( Figure 5G ). We compared this result to the enrichment for pairs of O-GlcNAc modifications in 3D proximity. Here, we found that observed pairs of these modifications are more likely to co-occur than expected by chance at less than 10Å ( Figure 5F ). This result supports the one determined from the sequence proximity analysis, indicating that there is little to no evolutionary pressure for crosstalk of these two types of PTMs within either type of proximity. 
Comparison with chemoenzymatic strategies for O-GlcNAc analysis
An alternative approach for the enrichment of O-GlcNAc-modified peptides involves the chemoenzymatic addition of biotinylated GalNAc to O-GlcNAc using an engineered version of galactosyl transferase (20) . This approach was used previously in combination with ETD to identify 141 sites of O-GlcNAcylation from mitotic spindle and midbodies (10) . A paper was published while this current manuscript was in review extending the chemoenzymatic strategy to identify 458 sites (52) . While our study identified several-fold more O-GlcNAc peptides, it is hard to compare the selectivity and sensitivity of the two approaches, because the biological samples studied and amounts employed were different and because the previous experiment was carried out in a cell line over-expressing OGT, thus elevating the level of modification above endogenous levels. A possible shortcoming of the chemoenzymatic approach is less than 100% efficiency of the enzymatic incorporation of the tag and/or photocleavage from the resin.
Despite the high coverage of O-GlcNAcylation at the spindle, only 3 of the 138 (2.1%) modified peptides reported previously (10) were doubly O-GlcNAcylated. In contrast, 439 of the 2,434 peptides (18%) in the current study were found to be multiply OGlcNAcylated. The chemoenzymatic approach may bias against multiply modified peptides (e.g. by limited enzyme efficiencies). In contrast, our chromatographic approach may bias in favor of multiply modified peptides because such peptides may be more efficiently separated from the flow-through peak during lectin-enrichment.
Physiological Role of O-GlcNAcylation in the brain
O-GlcNAcylation plays a critical role in neuronal biology. Neuron-specific knockout of OGT leads to early postnatal death, which suggests a role for this enzyme in essential pathways (5) . Both OGT and OGA are enriched at synapses (2) failure to find phosphopeptides corresponding to threonine residues 305/306 despite identifying over 16,500 phosphorylation sites suggests that the phosphorylation stoichiometry of these residues is low. Proteomic analyses (such as ours) typically rely on data-dependent acquisition of MS/MS spectra, which is biased towards the identification of abundant peptides. We cannot therefore rule out the possibility that phosphorylation at threonine residues 305/306 was present at some low level and that we failed to identify these sites due to chance. This example highlights the future need to determine the absolute occupancy of alternative site-specific PTMs as an important step towards understanding their respective functional roles for all sites that are affected by both PTMs.
The microtubule associated protein tau is extensively phosphorylated (for a review on tau PTMs, see (57) and has been reported to be modified by O-GlcNAc (58), giving rise to the hypothesis that O-GlcNAc may be regulating levels of tau phosphorylation (59) . We identified 112 unique tau peptides, including 67 phosphopeptides mapping to 46 sites of phosphorylation. However, we did not find any peptides corresponding to O-GlcNAcylation on tau. This finding calls into question whether endogenous synaptic tau in healthy young animals is sufficiently OGlcNAcylated to significantly modulate its phosphorylation site occupancies.
O-GlcNAcylation sites are often found in local clusters
Our dataset allowed for the first time to address whether or not O-GlcNAcylation sites are randomly distributed or occur in local clusters on the primary protein sequence or within 3D distance. Our data strongly support the presence of local clusters of OGlcNAcylation sites on the primary sequence with a distribution that is akin to but distinct from the one described for serine/threonine phosphorylation sites (48) GlcNAcylation at a distinct site may not be necessary and sufficient to cause a biological effect, nor may a O-GlcNAcylation-null mutation at a single site within a cluster be sufficient to test for a phenotype.
PTMs can potentially crosstalk at multiple levels
Crosstalk between the two types of PTMs can occur via three distinct yet potentially simultaneous mechanisms. A: Crosstalk at the level of substrate where addition of one PTM directly regulates the ability of an enzyme to add the second PTM (structural crosstalk). B: Crosstalk at the enzymatic level where one type of PTM modifies enzymes responsible for the addition/removal of the second PTM, thus regulating their activity (catalytic crosstalk). C: Crosstalk where addition of one PTM changes the sub-cellular localization of the substrate and thereby regulates the ability of substrate to be modified by the second PTM (localization crosstalk) (61) .
In this study, we identified 135 instances of individual serine and threonine residues alternatively modified by both O-GlcNAcylation and phosphorylation.
Previously, fewer than 20 such instances have been reported in the literature (6) . The scope of our analysis allowed us to demonstrate that the frequency of alternatively modified sites was essentially equal to the frequency expected by chance alone. Thus, our data suggests that there is no common evolutionary pressure to increase local In addition to demonstrating that kinases and OGT do not preferentially target the same residues, we also show that the distribution of these two post-translational modifications do not co-cluster on proteins. Therefore, it does not appear to be a This is consistent OGT and kinases having independently evolved substrate site specificity. It also indicates that at the proteome level, there was no evolutionary advantage to promote local spatial crosstalk between these two PTMs. (B) The UV trace during three sequential runs of lectin chromatography. In each case, an aliquot of GlcNAc (eluting at 2.5 ml) was used to release tightly binding peptides.
Peptides were collected as a single fraction starting at 1.2 ml, desalted and re-run for a total of three rounds. The UV shift to later elution times corresponded with a subsequent enrichment in the percentage or peptides that were O-GlcNAc-modified. Peptides from the O-GlcNAc enrichment were analyzed using ETD, while those from the phosphopeptides enrichment were analyzed using CID. The protein-protein interface between OGT and each docked substrate was examined.
Charged OGT surface residues were identified along with oppositely charged substrate residues in which their charged moiety was found within 10Å of and oriented towards the charged OGT residue.
(C) Four residues on OGT that were found to make frequent contacts with a range of substrates are shown. The positions of these four residues are shown in red on the OGT catalytic domain.
(D) aspartate 471 shown potentially interacting residues from six substrates (Q9D1Q6-Lys106; P18760-Lys22; Q61423-Arg28; Q8OX68-Lys393; Q9CQA3-Lys139; Q8K4S1-Lys2216) (E) arginine 475 shown potentially interacting residues from eight substrates (P18760-Asp17; P62874-Glu172; Q3UHK5-Glu228; Q9CQA3-Asp50; Q9D1Q6-Asp324; Q9CZ13-Glu157; Q3UHK5-Asp640; Q8K4S1-Asp2194).
(F) histidine 558 shown potentially interacting residues from four substrates (Q80X68-Asp455; P97450-Asp88; Q9CZ13-Glu157; P62874-Glu138).
(G) arginine 491 shown potentially interacting residues from five substrates (P14094-Asp270; Q8K4S1-Glu2171; P12787-Asp60; Q3UHK5-Glu221; Q9D1Q6-Glu290). See also Figure S3 . 
